Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 14/20 | 0.65 |
| ▸ | CA2 | P00918 | 14/20 | 0.65 |
| ▸ | CA7 | P43166 | 14/20 | 0.65 |
| ▸ | CA9 | Q16790 | 14/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.65 |
| ▸ | TSHR | P16473 | 2/20 | 0.65 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.65 |
| ▸ | CASP1 | P29466 | 2/20 | 0.65 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.65 |
| ▸ | RECQL | P46063 | 1/20 | 0.65 |
| ▸ | BACE1 | P56817 | 1/20 | 0.65 |
| ▸ | EHMT2 | Q96KQ7 | 1/20 | 0.65 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.65 |
| ▸ | CA4 | P22748 | 3/20 | 0.52 |
| ▸ | GSTP1 | P09211 | 1/20 | 0.40 |
| ▸ | NQO1 | P15559 | 1/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | CASP7 | P55210 | 1/20 | 0.39 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL6363255 | 0.98 | CA1 (0.62) | CA1CA2CA7CA9ALDH1A1 | |
| SCHEMBL14575653 | 0.96 | CA1 (0.60) | CA1CA2CA7CA9ALDH1A1 | |
| SCHEMBL29350272 | 0.79 | CA1 (1.00) | CA1CA2CA7CA9ALDH1A1 | |
| SCHEMBL3658029 | 0.79 | CA1 (1.00) | CA1CA2CA7CA9ALDH1A1 | |
| SCHEMBL17986 | 0.79 | CA1 (1.00) | CA1CA2CA7CA9ALDH1A1 | |
| SCHEMBL24756167 | 0.79 | CA1 (0.61) | CA1CA2CA7CA9ALDH1A1 | |
| Water SCHEMBL592691 | 0.77 | CA1 (0.94) | CA1CA2CA7CA9ALDH1A1 | |
| Ammonia Solution, Strong SCHEMBL1286269 | 0.77 | CA1 (0.94) | CA1CA2CA7CA9ALDH1A1 | |
| Hydrochloric Acid SCHEMBL28516500 | 0.77 | CA1 (0.94) | CA1CA2CA7CA9ALDH1A1 | |
| SCHEMBL4921601 | 0.77 | CA1 (0.94) | CA1CA2CA7CA9ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3597184-B1 | INDANONE DERIVATIVES, PHARMACEUTICALLY ACCEPTABLE SALTS OR OPTICAL ISOMERS THEREOF, PREPARATION METHOD FOR SAME, AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING VIRAL DISEASES | KOREA RES INST CHEMICAL TECH (KR) | 2026-03-04 | — | — | EP | disclosed |
| EP-2722042-B1 | INDANONE DERIVATIVES, PHARMACEUTICALLY ACCEPTABLE SALTS OR OPTICAL ISOMERS THEREOF, PREPARATION METHOD FOR SAME, AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING VIRAL DISEASES | KOREA RES INST CHEMICAL TECH (KR) | 2019-05-29 | — | — | EP | disclosed |
| US-9890133-B2 | Indanone derivatives, pharmaceutically acceptable salts or optical isomers thereof, preparation method for same, and pharmaceutical compositions containing same as active ingredient for preventing or treating viral diseases | KATHOLIEKE UNIVERSITEIT LEUVEN K.U. LEUVEN R&D (BE) | 2018-02-13 | — | — | US | disclosed |
| US-20160297789-A1 | INDANONE DERIVATIVES, PHARMACEUTICALLY ACCEPTABLE SALTS OR OPTICAL ISOMERS THEREOF, PREPARATION METHOD FOR SAME, AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING VIRAL DISEASES | KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) | 2016-10-13 | — | — | US | disclosed |
| US-9464067-B2 | Indanone derivatives, pharmaceutically acceptable salts or optical isomers thereof, preparation method for same, and pharmaceutical compositions containing same as active ingredient for preventing or treating viral diseases | KATHOLIEKE UNIVERSITEIT LEUVEN K.U. LEUVEN R & D (BE) | 2016-10-11 | — | — | US | disclosed |
| US-20140114068-A1 | INDANONE DERIVATIVES, PHARMACEUTICALLY ACCEPTABLE SALTS OR OPTICAL ISOMERS THEREOF, PREPARATION METHOD FOR SAME, AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING VIRAL DISEASES | KATHOLIEKE UNIVERSITEIT LEUVEN K.U. LEUVEN R & D (BE) | 2014-04-24 | — | — | US | disclosed |
| EP-2722042-A2 | INDANONE DERIVATIVES, PHARMACEUTICALLY ACCEPTABLE SALTS OR OPTICAL ISOMERS THEREOF, PREPARATION METHOD FOR SAME, AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING VIRAL DISEASES | Korea Research Institute of Chemical Technology (KR) | 2014-04-23 | — | — | EP | disclosed |
| US-8338028-B2 | Electrode active material for power storage device, power storage device, and electronic and transport devices | PANASONIC CORPORATION (JP) | 2012-12-25 | — | — | US | disclosed |
| US-20100196758-A1 | ELECTRODE ACTIVE MATERIAL FOR POWER STORAGE DEVICE, POWER STORAGE DEVICE, AND ELCTRONIC AND TRANSPORT DEVICES | PANASONIC CORPORATION (JP) | 2010-08-05 | — | — | US | disclosed |
| US-7629400-B2 | Image making medium | HYMAN SYDNEY | 2009-12-08 | — | — | US | disclosed |
| WO-2009118990-A1 | ELECTRODE ACTIVE MATERIAL FOR ELECTRICITY STORAGE DEVICE, ELECTRICITY STORAGE DEVICE, ELECTRONIC DEVICE AND TRANSPORT DEVICE | パナソニック株式会社 (JP) | 2009-10-01 | — | — | WO | disclosed |
| US-20080248583-A1 | Quantitative and Qualitative Chelation Measuring Methods and Materials | ALBION LABORATORIES, INC. (US) | 2008-10-09 | — | — | US | disclosed |
| US-20080248583-A1 | Quantitative and Qualitative Chelation Measuring Methods and Materials | ALBION LABORATORIES, INC. (US) | 2008-10-09 | — | — | US | disclosed |
| US-20080248583-A1 | Quantitative and Qualitative Chelation Measuring Methods and Materials | ALBION LABORATORIES, INC. (US) | 2008-10-09 | — | — | US | disclosed |
| US-20030035917-A1 | Image making medium | HYMAN SYDNEY (US) | 2003-02-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160297789-A1 | INDANONE DERIVATIVES, PHARMACEUTICALLY ACCEPTABLE SALTS OR OPTICAL ISOMERS THEREOF, PREPARATION METHOD FOR SAME, AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING VIRAL DISEASES | RNASE1, IAPP, TESK1 | CA1 2725/4885CA2 3443/4885CA7 2412/4885 |
| US-20100196758-A1 | ELECTRODE ACTIVE MATERIAL FOR POWER STORAGE DEVICE, POWER STORAGE DEVICE, AND ELCTRONIC AND TRANSPORT DEVICES | CXCR5, CX3CR1, CCR7 | CA1 1072/4885CA2 1782/4885CA7 771/4885 |
| US-20140114068-A1 | INDANONE DERIVATIVES, PHARMACEUTICALLY ACCEPTABLE SALTS OR OPTICAL ISOMERS THEREOF, PREPARATION METHOD FOR SAME, AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING VIRAL DISEASES | RNASE1, IAPP, FOXK1 | CA1 2694/4885CA2 3617/4885CA7 2847/4885 |
| US-20080248583-A1 | Quantitative and Qualitative Chelation Measuring Methods and Materials | AAAS, LIG4, HAMP | CA1 1739/4885CA2 2737/4885CA7 2509/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.